BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26657820)

  • 1. Can persons with a history of multiple addiction treatment episodes benefit from technology delivered behavior therapy? A moderating role of treatment history at baseline.
    Kim SJ; Marsch LA; Acosta MC; Guarino H; Aponte-Melendez Y
    Addict Behav; 2016 Mar; 54():18-23. PubMed ID: 26657820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome from computer-based treatment for substance use disorders: Results from a randomized clinical trial.
    Kim SJ; Marsch LA; Guarino H; Acosta MC; Aponte-Melendez Y
    Drug Alcohol Depend; 2015 Dec; 157():174-8. PubMed ID: 26433562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.
    Marsch LA; Guarino H; Acosta M; Aponte-Melendez Y; Cleland C; Grabinski M; Brady R; Edwards J
    J Subst Abuse Treat; 2014 Jan; 46(1):43-51. PubMed ID: 24060350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
    Lister JJ; Greenwald MK; Ledgerwood DM
    J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satisfaction With Methadone Among Heroin-Dependent Patients With Current Substance Use Disorders During Methadone Maintenance Treatment.
    Perez de Los Cobos J; Trujols J; SiƱol N; Duran-Sindreu S; Batlle F
    J Clin Psychopharmacol; 2016 Apr; 36(2):157-62. PubMed ID: 26825608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
    Salsitz E; Wiegand T
    J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose versus moderate dose methadone maintenance: is there a better outcome?
    Fareed A; Casarella J; Roberts M; Sleboda M; Amar R; Vayalapalli S; Drexler K
    J Addict Dis; 2009 Oct; 28(4):399-405. PubMed ID: 20155609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
    Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
    Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral contingencies improve counseling attendance in an adaptive treatment model.
    Brooner RK; Kidorf MS; King VL; Stoller KB; Peirce JM; Bigelow GE; Kolodner K
    J Subst Abuse Treat; 2004 Oct; 27(3):223-32. PubMed ID: 15501375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis.
    King JB; Sainski-Nguyen AM; Bellows BK
    J Pain Palliat Care Pharmacother; 2016; 30(1):55-65. PubMed ID: 27007583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.